Axcella Health Inc.
AXLADelisted Feb 15, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001633070
Axcella Health Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Mar 3, 2023; 15 institutions reported holding it in 13F filings for Q3 2023, worth $17.1M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Axcella Health Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 44 | 38 | −6 |
| Shares | 25.6M | 24.3M | −1.29M (−5.1%) |
| Value | $121.7M | $97.3M | −$24.4M (−20.0%) |
New holders (8)
Institutions that held Axcella Health Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ergoteles LLC | 64,015 | $257.0K | 0.01% |
| HRT Financial LP | 43,894 | $176.0K | 0.00% |
| Cutter & CO Brokerage, Inc. | 35,300 | $142.0K | 0.03% |
| ExodusPoint Capital Management, LP | 33,424 | $134.0K | 0.00% |
| Edgewood Management LLC | 25,000 | $100.0K | 0.00% |
| TownSquare Capital, LLC | 11,950 | $52.0K | 0.00% |
| First Manhattan Co | 2,000 | $8.00K | 0.00% |
| American Portfolios Advisors | 400 | $1.60K | 0.00% |
Sold out (14)
Institutions that held Axcella Health Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Jacobs Levy Equity Management, Inc | 129,108 | $615.0K |
| Nuveen Asset Management, LLC | 64,749 | $308.0K |
| Two Sigma Investments, LP | 44,901 | $214.0K |
| California State Teachers Retirement System | 22,760 | $108.0K |
| Invesco Ltd. | 10,769 | $51.0K |
| Rhumbline Advisers | 10,150 | $48.0K |
| Deutsche Bank AG | 9,609 | $46.0K |
| American International Group, Inc. | 9,025 | $43.0K |
| Tower Research Capital LLC (TRC) | 3,562 | $17.0K |
| Legal & General Group Plc | 1,541 | $7.00K |
| Citigroup Inc | 1,126 | $5.00K |
| Hoover Financial Advisors, Inc. | 1,000 | $3.00K |
| Bank of Montreal | 505 | $2.00K |
| Ameritas Investment Partners, Inc. | 145 | $1.00K |